NuChem Therapeutics
Business Services · Canada · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
6100 Royalmount Ave, Montreal, Quebec, H...Phone Number
(514) 416-5659Website
www.nuchemsciences.comRevenue
$43.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About NuChem Therapeutics
NuChem Therapeutics offers a variety of services to support international biotech and pharmaceuticals industries, to help identify and optimise pre-clinical candidates in the area of small molecule drug discovery and early development. Since its inception in 2011, NuChem has contributed to the discovery of several new drug candidates which have progressed to human clinical trials.Explore more
NuChem Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NuChem Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at NuChem Therapeutics
Check out if NuChem Therapeutics is spiking on competitors!
Click to see if NuChem Therapeutics had a recent Job posting/layoffs
Check if NuChem Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on NuChem Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
NuChem Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once NuChem Therapeutics has new funding data
Product Launch: Get notified when NuChem Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined NuChem Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to NuChem Therapeutics
Compare insights from companies similar to NuChem Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NuChem Therapeutics
$43.3M
501-1,000
Private
-
2011
DG
Daniel GuayPartner, Executive Vice President and CSO
$35.6M
201-500
Private
-
1989
MN
Myoe NaingAnimal Health (Pre Technologist & Chief Revenue Officer, Clinical Translational )
Company Profile Activity
Activity Insights
NuChem Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NuChem Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NuChem Therapeutics.
NuChem Therapeutics Tech Stack
A closer look at the technologies used by NuChem Therapeutics
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Mergers & Acquisitions (M&A)
Event
NuChem Therapeutics News & Media
SYGNATURE DISCOVERY ACCELERATES GLOBAL GROWTH WITH MAJOR NORTH AMERICAN ACQUISITION
NOTTINGHAM, England, Aug. 1, 2023 /PRNewswire/ -- Leading integrated drug discovery partner, Sygnature Discovery ("Sygnature") has announced its acquisition of one of North America's largest discovery Contract Research Organisations, Canada-based NuChem Sciences. This acquisition cements...Fonds de solidarité FTQ backs NuChem’s acquisition of IniXium
The acquisition allows NuChem to broaden its expertise in biological targets whose manufacturing and understanding of their 3D structure are essential steps in the creation of new drugs. The post Fonds de solidarité FTQ backs NuChem’s acquisition of IniXium appeared first on PE Hub.NuChem Therapeutics Completed the Acquisition of Amplia Pharmatek.
MONTRÉAL--(BUSINESS WIRE)--NuChem Therapeutics completes the acquisition of Amplia PharmatekNuChem completes MBO
Montreal-based NuChem Therapeutics Inc, a drug discovery and development contract research organization, has completed a management buyout from Amorchem LP. No financial terms were disclosed. According to details of the transaction, NuChem's senior management acquired 95 percent of the voting shares from Amorchem, a Montreal-based early-stage venture firm that founded NuChem in 2011.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NuChem Therapeutics
Sign Up For FreeTo access detailed company insights
NuChem Therapeutics offers a variety of services to support international biotech and pharmaceuticals industries, to help identify and optimise pre-clinical candidates in the area of small molecule drug discovery and early development. Since its inception in 2011, NuChem has contributed to the discovery of several new drug candidates which have pro... Read More
